The official blog of the Lung Institute.

What Causes Pulmonary Fibrosis Lung Disease?

8 Aug 2017
| Under Lung Disease, Pulmonary Fibrosis | Posted by | 8 Comments
Lung Graphic

Pulmonary fibrosis is a condition characterized by the development of scarring (fibrosis) in and around the air sacs (alveoli) of the lungs. The resulting thickening and stiffening of lung tissue can lead to breathing difficulties and make it difficult for essential oxygen to pass into the bloodstream. The symptoms of pulmonary fibrosis often worsen over time, sometimes to the point that an individual may experience shortness of breath even while at rest.

In most cases, the precise cause of pulmonary fibrosis is unknown (this is referred to as idiopathic pulmonary fibrosis). However, the condition can sometimes be traced to exposure to certain substances and conditions, including:

  • Toxins – Long-term exposure to certain toxins and pollutants, such as asbestos fibers, coal dust, silica dust, hard metal dust, grain dust and bird and animal droppings, can damage the lungs.
  • Radiation – Prior radiation therapy administered to the chest area, such as that used to treat breast or lung cancer, can potentially cause lung damage (which sometimes develops several months or even years later).
  • Medications – The use of certain drugs, including some antibiotics, anti-inflammatories, heart medications and chemotherapy medications, can sometimes damage lung tissue.
  • Other medical conditions – Lung damage can result from a number of underlying health conditions, including sarcoidosis, dermatomyositis, polymyositis, systemic lupus erythematosus, rheumatoid arthritis, scleroderma, pneumonia and mixed connective tissue disease.

Scientists continue to investigate possible causes of idiopathic pulmonary fibrosis. Some researchers believe the lung scarring may be triggered by a virus or exposure to tobacco smoke. Additionally, idiopathic pulmonary fibrosis appears to sometimes run in families, leading experts to theorize that heredity may play a role in its development. While many people who are diagnosed with idiopathic pulmonary fibrosis also have gastroesophageal reflux disease (GERD), more studies are needed to determine whether there is an actual link between the two conditions.

If you are exploring treatment options for pulmonary fibrosis, you are encouraged to contact the Lung Institute at (800) 729-3065. As a world-recognized leader in stem cell therapy for chronic lung diseases, we offer stem cell therapy as an innovative form of pulmonary fibrosis treatment. By harnessing the power of adult stem cells, our groundbreaking therapy can potentially promote healing, improve lung function and enhance quality of life.


  1. Lung Institute

    3 months ago


    Thank you for your question. Unfortunately, we are not the right people to respond to that question. We would suggest you see your primary doctor or a specialist. Both pulmonary fibrosis and histoplasmosis are lung diseases but are not necessarily similar.

    We’re happy to answer your questions about stem cell therapy for chronic lung diseases. We have a dedicated medical team who have a wealth of knowledge about stem cells, treatment options, candidacy, cost and more. So, feel free to give us a call at (855) 313-1149. We look forward to hearing from you soon.


    The Lung Institute

  2. elizabeth

    3 months ago

    doew anyone know if lung scarring from histoplasmosis when a teen can develop into pulmonary fibrosis in later adult life?

  3. Lung Institute

    6 months ago


    Thank you for your comment. Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Please don’t hesitate to reach out if you have any additional questions and we’d be happy to help.


    Lung Institute

  4. Lung Institute

    6 months ago


    Thank you for contacting us. We are sorry to hear about your condition. We may be able to offer some treatment and relief.

    I would suggest contacting one of our patient coordinators. They will be happy to discuss your specific situation and answer your questions about stem cell therapy. So feel free to contact us at (855) 313-1149 to speak one-on-one with a patient coordinator. We look forward to hearing from you soon.


    The Lung Institute

  5. Linda J Murray

    6 months ago


  6. Lung Institute

    6 months ago


    Excessive exposure to mold and/or mildew can have an impact on your lungs’ health. If you are concerned about exposure, please consult with your primary care physician, who will be able to provide you with guidance and suggestions for better lung health.


    Lung Institute

  7. Ronald meeks

    7 months ago

    Does EXCESSIVE exposure to mold and mildew cause the progression of lung disease. Can it cause ipf over time along with exposure to asbestos?

  8. Rose Llewellyn

    7 months ago

    I thought that stem cell therapy haD not been passed for treatment Of IPF by the FDA. Has this changed?

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.